Olivier Kitten
Founder & Chief Executive Officer Affilogic
Seminars
Thursday 21st May 2026
Pioneering Intranasal Delivery of mRNA, Antibodies, and Biologics to Unlock New Therapeutic Possibilities
2:30 pm
- New small biologics fit for nasal delivery & biophysical attributes
- Demonstration of preclinical efficacy of inhaled biological antivirals
- Impact on mucosal immunity
